Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease
- 5 July 2005
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (8) , 1110-1117
- https://doi.org/10.1016/j.neurobiolaging.2005.06.003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Plasticity of Glutamate and GABAA Receptors in the Hippocampus of Patients with Alzheimer's DiseaseCellular and Molecular Neurobiology, 2003
- Gene expression profiling in the post-mortem human brain — no cause for dismayJournal of Chemical Neuroanatomy, 2001
- Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorderPsychiatry Research, 2001
- Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementiaBehavioural Brain Research, 2000
- The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's diseaseInternational Journal of Neuropsychopharmacology, 2000
- Spatial distribution of GABABR1 receptor mRNA and binding sites in the rat brainJournal of Comparative Neurology, 1999
- The Alzheimer's disease assessment scaleNeurology, 1997
- Neuropsychiatric aspects of Alzheimer's diseaseNeurology, 1996
- Presynaptic Serotonergic Markers in Community‐Acquired Cases of Alzheimer's Disease: Correlations with Depression and Neuroleptic MedicationJournal of Neurochemistry, 1996
- Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victimsBrain Research, 1988